We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTPZ icon
1626
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$745M
$3.68M ﹤0.01%
+63,212
New +$3.7M
FBK icon
1627
FB Financial Corp
FBK
$3.1B
$3.68M ﹤0.01%
101,759
-12,500
-11% -$501K
BOX icon
1628
Box
BOX
$4.66B
$3.68M ﹤0.01%
118,095
+38,620
+49% +$1.1M
IART icon
1629
Integra LifeSciences
IART
$1.42B
$3.68M ﹤0.01%
65,548
+22,151
+51% +$1.13M
ATRI
1630
DELISTED
Atrion Corp
ATRI
$3.67M ﹤0.01%
6,563
-602
-8% -$363K
SF
1631
Stifel
SF
$12.9B
$3.67M ﹤0.01%
94,226
-9,061
-9% -$358K
FYC icon
1632
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.41B
$3.65M ﹤0.01%
66,086
-8,794
-12% -$501K
RITM icon
1633
Rithm Capital
RITM
$5.79B
$3.65M ﹤0.01%
447,009
-2,028
-0.5% -$16.9K
OLLI icon
1634
Ollie's Bargain Outlet
OLLI
$4.7B
$3.64M ﹤0.01%
77,703
-4,296
-5% -$232K
EXAS
1635
DELISTED
Exact Sciences
EXAS
$3.64M ﹤0.01%
73,454
+56
+0.1% +$2.29K
DMB
1636
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$197M
$3.63M ﹤0.01%
345,825
-11,721
-3% -$126K
HQL
1637
abrdn Life Sciences Investors
HQL
$643M
$3.63M ﹤0.01%
255,483
+85,818
+51% +$1.24M
AGCO icon
1638
AGCO
AGCO
$6.96B
$3.63M ﹤0.01%
26,167
-3,861
-13% -$476K
PAYC icon
1639
Paycom
PAYC
$10.1B
$3.63M ﹤0.01%
11,690
+106
+0.9% +$34.2K
FGD icon
1640
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.6B
$3.62M ﹤0.01%
164,788
-222,263
-57% -$4.61M
USTB icon
1641
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.4B
$3.62M ﹤0.01%
74,372
+5,772
+8% +$280K
PIPR icon
1642
Piper Sandler
PIPR
$5.54B
$3.62M ﹤0.01%
111,116
-1,872
-2% -$61.1K
SHLS icon
1643
Shoals Technologies Group
SHLS
$1.37B
$3.61M ﹤0.01%
146,180
+27,120
+23% +$655K
INDB icon
1644
Independent Bank
INDB
$4.05B
$3.6M ﹤0.01%
42,625
+23,540
+123% +$2M
XMLV icon
1645
Invesco S&P MidCap Low Volatility ETF
XMLV
$747M
$3.6M ﹤0.01%
67,208
+68
+0.1% +$3.58K
JBTM
1646
JBT Marel
JBTM
$6.1B
$3.59M ﹤0.01%
39,344
-9,341
-19% -$855K
CTRE icon
1647
CareTrust REIT
CTRE
$9.18B
$3.59M ﹤0.01%
193,021
-402,157
-68% -$7.51M
NZF icon
1648
Nuveen Municipal Credit Income Fund
NZF
$2.45B
$3.58M ﹤0.01%
296,711
+64,401
+28% +$745K
GH icon
1649
Guardant Health
GH
$21.4B
$3.58M ﹤0.01%
131,464
-19,888
-13% -$910K
PSK icon
1650
State Street SPDR ICE Preferred Securities ETF
PSK
$685M
$3.57M ﹤0.01%
108,891
-1,782
-2% -$60.1K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.